临床表现 临床表现
Akira Arakawa1, Tomoyasu Matsubara1, Manato Hara1
1Brain Bank for Aging Research, Tokyo Metropolitan Geriatric Hospital and Institute of Gerontology, Tokyo, Tokyo, Japan.
Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 25, 2025
概括
阿吉罗菲尔粒细胞疾病 (AGD) 与痴呆症有关,特别是在赛托第三阶段. 帕金森症的症状,包括姿势不稳定,也可能常见于AGD患者.
科学领域:
- 神经病理学神经病理学
- 老年医学 老年医学
- 神经退行性疾病 神经退行性疾病
背景情况:
- 阿尔吉罗菲尔粒细胞疾病 (AGD) 是一种与年龄相关的神经病理,其特征是阿尔吉罗菲尔粒细胞和顺序分布模式 (赛托阶段).
- AGD与痴呆症和帕金森症的临床关联仍在争论中.
- 这项研究旨在通过日本尸检队列来澄清这些关联.
研究的目的:
- 调查阿吉罗菲尔粒细胞疾病 (AGD) 和痴呆症之间的临床病理关系.
- 为了确定AGD与帕金森症的关联.
- 分析赛托阶段对痴呆症严重程度的影响.
主要方法:
- 从老龄化研究大脑银行 (BBAR) 队列 (2012-2022) 中对452例尸检病例进行了回顾性分析.
- 评估年龄,赛托阶段和CDR得分与AGD存在的关系.
- 选择纯 AGD 与痴呆病例 (CDR ≥1,布拉克阶段 ≤2,BBAR Lewy阶段 ≤1) 进行详细的临床特征检查.
主要成果:
- 在50.2% (227/452) 的病例中存在AGD,患病率和Saito阶段随着年龄的增加而增加.
- 与AGD阴性病例 (27.1%,0.8 ± 1.2) 相比,AGD阳性病例的痴呆率 (46.7%) 和CDR得分 (1.2 ± 1.2) 显着更高.
- 赛托第三阶段病例表现出最高的痴呆率 (77.6%) 和CDR得分 (1.7±1.0). 在20例纯 AGD 痴呆病例中,有6例呈现出帕金森症.
结论:
- 阿吉罗菲尔粒细胞疾病 (AGD) 与痴呆症有很强的关联,特别是在晚期的Saito阶段.
- 帕金森症,特别是姿势不稳定,是AGD的潜在临床表现.
- 这些发现突出显示了AGD对老年人群认知和运动功能的重大影响.
相关概念视频
Chronic Kidney Disease II: Clinical Manifestations
520
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
520
Coronary Artery Disease III: Clinical Manifestations
299
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
299
Endocarditis II: Clinical Features of Infective Endocarditis
364
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
364
Heart Failure III: Clinical Manifestations
436
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
436
Gastroesophageal Reflux Disease II: Clinical Features and Management
652
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
652
Hypertension III: Clinical Manifestations and Diagnostic Studies
437
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
437


